Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance
- 1 September 1991
- journal article
- case report
- Published by Springer Nature in Diabetologia
- Vol. 34 (9) , 675-679
- https://doi.org/10.1007/bf00400998
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Therapeutic potential of insulinlike growth factor iTrends in Endocrinology & Metabolism, 1990
- Insulin Receptor Structure and Function in Normal and Pathological ConditionsAnnual Review of Medicine, 1990
- Human Diabetes Associated with a Mutation in the Tyrosine Kinase Domain of the Insulin ReceptorScience, 1989
- Human Diabetes Associated with a Deletion of the Tyrosine Kinase Domain of the Insulin ReceptorScience, 1989
- Detection of an Alteration in the Insulin-Receptor Gene in a Patient with Insulin Resistance, Acanthosis Nigricans, and the Polycystic Ovary Syndrome (Type A Insulin Resistance)New England Journal of Medicine, 1988
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987
- Insulin receptor biosynthesis in cultured lymphocytes from insulin-resistant patients.Journal of Clinical Investigation, 1985
- Insulin‐Like Growth Factors I and II: Some Biological Actions and Receptor Binding Characteristics of Two Purified Constituents of Nonsuppressible Insulin‐Like Activity of Human SerumEuropean Journal of Biochemistry, 1978
- Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heartBiochemical and Biophysical Research Communications, 1977
- Radioimmunological determination of human C-peptide in serumDiabetologia, 1975